Fulcrum Therapeutics, Inc. (Nasdaq:FULC)
Health Care/Life Sciences • Biotechnology
CIK 1680581
Company
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Address
26 Landsdowne Street
Cambridge, Massachusetts 02139
26 Landsdowne Street
Cambridge, Massachusetts 02139
Employees
76
76
Stock Info
Key Executives
Board Of Directors
President, Chief Executive Officer & Director Alexander C Sapir MBA |
Director Robert J Gould PhD |
Chairman Kathryn Haviland MBA |
Independent Director James Arthur Geraghty |
Independent Director Sonja L Banks |
Independent Director Katina Dorton MBA |
Independent Director James J Collins PhD |
Independent Director R. Alan B Ezekowitz PhD |
SEC filings
Date | Form | Event |
---|---|---|
23 Aug, 2024 | SC 13G/A | |
23 Aug, 2024 | 4 | |
22 Aug, 2024 | 8-K | |
31 Jul, 2024 | S-8 | |
31 Jul, 2024 | 10-Q | |
31 Jul, 2024 | 8-K | |
8 Jul, 2024 | 4 | |
18 Jun, 2024 | 3 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
17 Jun, 2024 | 8-K | |
13 May, 2024 | 8-K | |
13 May, 2024 | 10-Q | |
9 May, 2024 | 4 | |
25 Apr, 2024 | EFFECT | |
24 Apr, 2024 | CORRESP | |
19 Apr, 2024 | DEFA14A | |
19 Apr, 2024 | ARS | |
19 Apr, 2024 | DEF 14A | |
20 Mar, 2024 | 3 | |
20 Mar, 2024 | 4 | |
8 Mar, 2024 | 4 | |
8 Mar, 2024 | 144 | |
5 Mar, 2024 | 4 | |
1 Mar, 2024 | UPLOAD | |
27 Feb, 2024 | S-3 | |
27 Feb, 2024 | 8-K | |
27 Feb, 2024 | S-8 | |
27 Feb, 2024 | 10-K | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G/A | |
7 Feb, 2024 | SC 13G/A | |
30 Jan, 2024 | 4 | |
30 Jan, 2024 | 4 | |
30 Jan, 2024 | 4 | |
7 Nov, 2023 | 8-K | |
7 Nov, 2023 | 10-Q | |
2 Oct, 2023 | 8-K | |
22 Aug, 2023 | 8-K | |
9 Aug, 2023 | 4 | |
9 Aug, 2023 | 3 | |
3 Aug, 2023 | 10-Q | |
3 Aug, 2023 | 8-K | CEO Change |
10 Jul, 2023 | 8-K | |
7 Jul, 2023 | SC 13G/A | |
3 Jul, 2023 | 3 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
29 Jun, 2023 | 4 | |
26 Jun, 2023 | 10-K/A | |
26 Jun, 2023 | 10-K/A | |
23 Jun, 2023 | 10-K/A | |
9 Jun, 2023 | 8-K | |
15 May, 2023 | 8-K | CEO Change |
15 May, 2023 | 10-Q | |
11 May, 2023 | 4 | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | 4 | |
28 Apr, 2023 | 4 | |
28 Apr, 2023 | DEF 14A | |
18 Apr, 2023 | PRE 14A | |
5 Apr, 2023 | 8-K | |
9 Mar, 2023 | S-8 | |
9 Mar, 2023 | 10-K | |
9 Mar, 2023 | 8-K | |
6 Mar, 2023 | SC 13G | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | 4 | |
13 Feb, 2023 | 4 | |
9 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | SC 13G/A | |
24 Jan, 2023 | 4 | |
23 Jan, 2023 | SC 13G/A | |
18 Jan, 2023 | 8-K | |
18 Jan, 2023 | 424B5 | |
17 Jan, 2023 | 8-K | |
17 Jan, 2023 | 424B5 | |
13 Jan, 2023 | 4 | |
6 Jan, 2023 | SC 13G/A | |
6 Jan, 2023 | 4 | |
4 Jan, 2023 | 8-K | CEO Change |
29 Dec, 2022 | 4 | |
21 Dec, 2022 | 4 | |
16 Dec, 2022 | 4 | |
15 Dec, 2022 | 4 | |
9 Nov, 2022 | 3 | |
9 Nov, 2022 | 4 | |
8 Nov, 2022 | 8-K | |
8 Nov, 2022 | 10-Q | |
19 Oct, 2022 | 8-K | |
26 Aug, 2022 | SC 13G | |
26 Aug, 2022 | 3 | |
23 Aug, 2022 | 8-K | |
17 Aug, 2022 | 424B5 | |
17 Aug, 2022 | 8-K | |
15 Aug, 2022 | 424B5 | |
11 Aug, 2022 | 4 | |
11 Aug, 2022 | 10-Q | |
11 Aug, 2022 | 4 | |
11 Aug, 2022 | 3 | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 8-K | |
19 Jul, 2022 | 4 | |
11 Jul, 2022 | 8-K | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
29 Jun, 2022 | 4 | |
22 Jun, 2022 | SC 13G | |
10 Jun, 2022 | 8-K | |
9 Jun, 2022 | 8-K | |
8 Jun, 2022 | 4 | |
6 Jun, 2022 | 4 | |
6 Jun, 2022 | 8-K | |
10 May, 2022 | 8-K | |
10 May, 2022 | 424B5 | |
10 May, 2022 | 4 | |
9 May, 2022 | POS EX | |
9 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
28 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | DEFA14A | |
28 Apr, 2022 | EFFECT | |
11 Apr, 2022 | 4 | |
5 Apr, 2022 | 4 | |
14 Mar, 2022 | 3 | |
10 Mar, 2022 | SC 13G | |
10 Mar, 2022 | 8-K | |
9 Mar, 2022 | SC 13G | |
3 Mar, 2022 | 8-K | |
3 Mar, 2022 | POS AM | |
3 Mar, 2022 | S-8 | |
3 Mar, 2022 | POSASR | |
3 Mar, 2022 | 10-K | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G | |
27 Jan, 2022 | S-8 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
10 Jan, 2022 | 3 | |
10 Jan, 2022 | 4 | |
10 Jan, 2022 | 8-K | |
7 Jan, 2022 | 5 | |
4 Jan, 2022 | 8-K | |
9 Dec, 2021 | 4 | |
9 Dec, 2021 | 3 | |
6 Dec, 2021 | 8-K | |
17 Nov, 2021 | 8-K | |
12 Nov, 2021 | 4 | |
12 Nov, 2021 | 4 | |
4 Nov, 2021 | 8-K | |
4 Nov, 2021 | S-3ASR | |
4 Nov, 2021 | 10-Q | |
27 Sep, 2021 | SC 13G/A | |
24 Sep, 2021 | 4 | |
24 Sep, 2021 | 4 | |
10 Sep, 2021 | SC 13G/A | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | 4 | |
12 Aug, 2021 | 424B5 | |
12 Aug, 2021 | 4 | |
11 Aug, 2021 | S-3MEF | |
11 Aug, 2021 | 424B5 | |
10 Aug, 2021 | SC 13G | |
10 Aug, 2021 | 10-Q | |
10 Aug, 2021 | 8-K | |
29 Jun, 2021 | 4 | |
29 Jun, 2021 | 4 | |
29 Jun, 2021 | 4 | |
29 Jun, 2021 | 4 | |
24 Jun, 2021 | 8-K | |
11 Jun, 2021 | 8-K | |
11 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
11 Jun, 2021 | 4 | |
12 May, 2021 | 4 | |
12 May, 2021 | 3 | |
6 May, 2021 | 8-K | |
6 May, 2021 | 10-Q | |
29 Apr, 2021 | DEFA14A | |
29 Apr, 2021 | DEF 14A | |
2 Apr, 2021 | 3 | |
2 Apr, 2021 | 4 | |
2 Apr, 2021 | 4 | |
24 Mar, 2021 | 8-K | |
22 Mar, 2021 | SEC STAFF | |
17 Mar, 2021 | 4 | |
4 Mar, 2021 | S-8 | |
4 Mar, 2021 | 10-K | |
4 Mar, 2021 | 8-K | CEO Change |
24 Feb, 2021 | 4 | |
22 Feb, 2021 | SEC STAFF | |
18 Feb, 2021 | 4 | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | 4 | |
10 Feb, 2021 | 3 | |
8 Feb, 2021 | SC 13G/A | |
4 Feb, 2021 | 4 | |
27 Jan, 2021 | 4 | |
27 Jan, 2021 | 4 | |
25 Jan, 2021 | 4 | |
22 Jan, 2021 | 4 | |
20 Jan, 2021 | 424B5 | |
20 Jan, 2021 | 8-K | |
19 Jan, 2021 | 424B5 | |
19 Jan, 2021 | 8-K |
Last update:2024-03-06 13:39:17.167512
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.